Published in Lab Business Week, July 23rd, 2006
Over the next two years, Corgentech may from time to time, at its discretion, sell registered shares of its common stock to Azimuth Opportunity at a small discount to the market price. Acqua Capital Management is an advisor to Azimuth Opportunity.
This flexible financing agreement provides access to additional resources to advance the company's product pipeline of pain therapeutics. Net proceeds will be used to provide working...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.